The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats

BMC Pharmacology
doi 10.1186/1471-2210-11-s1-p43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats

PLoS ONE
Multidisciplinary
2012English

EXPRESS: First-In-Child Use of the Oral Soluble Guanylate Cyclase Stimulator Riociguat in Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2017English

Effects of Age and Sex on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)

Pulmonary Circulation
PulmonaryRespiratory Medicine
2016English

The Effects of the Soluble Guanylate Cyclase Stimulator Riociguat on Memory Performance in Healthy Volunteers With a Biperiden-Induced Memory Impairment

Psychopharmacology
Pharmacology
2018English

Soluble Guanylate Cyclase Stimulators and Phosphodiesterase-5 Inhibitors in Therapy of Some Groups of Pulmonary Hypertension

Pulmonologiya
PulmonaryRespiratory Medicine
2018English

Molecular Steps in Soluble Guanylate Cyclase Activation

BMC Pharmacology
2005English

Iptakalim Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in Rats by Endothelial Function Protection

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Inhaled and Intravenous Application of a Stimulator of the Soluble Guanylate Cyclase (BAY 41-8543) Reduces Pulmonary Vascular Resistance in a Model of Septic Shock

BMC Pharmacology
2011English

Role of Riociguat in Treatment of Exercise-Induced Pulmonary Hypertension

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy